testolactone (Teslac, Fludestrin)

Indications

• adjunctive therapy in palliative treatment of metastatic breast cancer (post-menopausal or with ovariectomy)

Laboratory

• testolactone in urine

Mechanism of action

• inhibition of steroid aromatase activity

More general terms

• aromatase inhibitor
• antineoplastic agent (chemotherapeutic agent)

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=13769
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=160753